GlaxoSmithKline plc (NYSE:GSK) traces its roots back to a London apothecary in 1715. But when Fortune Magazine compiled its “Change the World” list -- the top 50 companies that are making money by tackling society’s biggest problems -- the venerable British drugmaker beat out all the younger innovators to take the top spot. There are lessons for the rest of the industry in that.
